Publications by authors named "Alan Zwart"

Claim this Profile
R
Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer: The Georgetown University Experience.
Vaibhav Sharma, Tim Kearney, Zach Lee, Padraig Brennan Pilkington, Marielle Fis Loperena, Alan L Zwart

Cureus· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy.
Diya Kallam, Kelly Gaudian, Ryan Collins, Zoya Zwart, Min Ji Koh, Alan L Zwart

Cureus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy.
Min Jung Koh, Min Ji Koh, Jessica Y Hsueh, Lindsey Gallagher, Malika Danner, Alan Zwart

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer.
Kelly Gaudian, Min Jung Koh, Min Ji Koh, Ryan R Collins, Shaine Eden, Zoya Zwart, Alan Zwart

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and Patterns of Potentially Salvageable Recurrences Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer Assessed by Preferential Amino Acid Uptake.
Tim Kearney, Lauren Nagel, Matthew Bourne, Alan L Zwart, Deepak Kumar

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late radiation-related lymphopenia after prostate stereotactic body radiation therapy plus or minus supplemental pelvic irradiation.
Kelly Gaudian, Min Jung Koh, Min Ji Koh, Peter Jermain, Irfan Khan, Zoya Zwart, Alan Zwart

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancer.
Min Ji Koh, Padraig Pilkington, Min Jung Koh, Mary-Kate Lawlor, Michael Creswell, Alan Zwart

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue.
Jessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, Sarthak Shah, Malika Danner, Alan Zwart

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning.
Lauren Ching, Matthew Bourne, Tim Kearney, Karbi Choudhury, Alan L Zwart

Cureus· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
Jessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, Shaine Eden, Sarthak Shah, Alan Zwart

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic utility of biopsy-based and status on biochemical progression and overall survival after SBRT for localized prostate cancer.
Michael C Repka, Tamir Sholklapper, Alan L Zwart, Malika Danner, Marilyn Ayoob

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
Sarthak Shah, Abigail Pepin, Simran Jatar, Jessica Hsueh, Lindsey Gallagher, Alan Zwart

Cureus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
Michael Carrasquilla, Tamir Sholklapper, Abigail N Pepin, Nicole Hodgins, Siyuan Lei, Alan Zwart

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Lindsey Gallagher, Jerry Xiao, Jessica Hsueh, Sarthak Shah, Malika Danner, Alan Zwart

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer.
Rishabh K Simhal, Tamir N Sholklapper, Anish K Simhal, Alan L Zwart, Malika T Danner

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Tamir Sholklapper, Michael Creswell, Jonathan Cantalino, Michael Markel, Alan Zwart

J Sex Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Tamir N Sholklapper, Michael L Creswell, Alexandra T Payne, Michael Markel, Abigail Pepin, Alan Zwart

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer.
Abigail N Pepin, Alan Zwart, Malika Danner, Marylin Ayoob, Thomas Yung

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies.
Julius Benicky, Miloslav Sanda, Zuzana Brnakova Kennedy, Oliver C Grant, Robert J Woods, Alan Zwart

J Proteome Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes.
Anni Wärri, Katherine L Cook, Rong Hu, Lu Jin, Alan Zwart

Cell Death Discov· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.
Hillary Stires, Mary M Heckler, Xiaoyong Fu, Zhao Li, Catherine S Grasso, Alan Zwart

Mol Cell Endocrinol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Leena Hilakivi-Clarke, Anni Wärri, Kerrie B Bouker, Xiyuan Zhang, Katherine L Cook, Alan Zwart

J Natl Cancer Inst· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer.
Katherine L Cook, David R Soto-Pantoja, Pamela A G Clarke, M Idalia Cruz, Alan Zwart

Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer.
Rong Hu, Anni Warri, Lu Jin, Alan Zwart, Rebecca B Riggins

Mol Cell Biol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
Katherine L Cook, Anni Wärri, David R Soto-Pantoja, Pamela Ag Clarke, M Idalia Cruz, Alan Zwart

Clin Cancer Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis